Pfleiderer - Never mind the 'spilt milk', comrades - Model Update
All,
Please find our updated analysis here.
Ahead of next week’s great reveal (or so we hope), we are keen to get in shape to pick up what could be an interesting opportunity. Pfleiderer is as much about a cyclical asset with an undiminished market share that’s waiting for its next wave, as it is about creditor on creditor behaviour, set down in the A&E, perhaps overhauled in the drop-down and to be tested again before the maturity of these bonds.
The drop-down seems to have been structurally more aggressive than it was fundamentally, and we are cautious not to cry over the spilt milk. Never mind the sponsor walking off with some assets.
Investment Considerations:
- We are unable to buy bonds on this information, but envisage this situation changing in the near future on the Q126 call. Conceptually, the bonds are trading at a fair valuation if their owner can assert their rights in the 2028 restructuring. Until then, they should provide a strong running yield and de-risk, while the fundamental picture should turn friendlier.
- Depending on what we learn of the creditor constellation in the near future, we could be tempted to buy at these levels, but keeping one eye on position size - either small enough to trade out again, or big enough to defend ourselves against - not against SVP next time, but against the majority holding AHG and other bondholders. In theory, inter creditor relations were already managed in the A&E.
Key Insights:
- The Maple transaction appears broadly creditor-friendly despite limited transparency. The sponsor has effectively paid €25m to extend its option value, using the Silekol drop-down and incremental debt to secure c.18–24 months of runway in which to re-establish an enterprise value anchored in cash flow rather than break-up dynamics (Current Trading; Recap Scenario; Model).
- As anticipated in summer '25, operationally EWP stabilised somewhat in Q4, with flat volumes and improved pricing, while EBITDA weakness was distorted by unusually strong Q4’24 comparables and CO2 timing effects and one-offs. However, the underlying price/volume backdrop remains weak and cost savings are progressing slowly, offset in part by higher capex (Current Trading; Model).
- Execution at Silekol remains comparatively solid. Project Nord is operationally complete, with full EBITDA contribution expected through 2026, alongside contributions from the UFC Tower and PF Reactor. We place less weight on the more opaque “efficiency projects” still to be realised (Current Trading; Model).
- The restructuring does not solve the capital structure. Pfleiderer remains unlikely to delever organically into 2029 maturities; rather, the transaction creates a window in which stakeholders may eventually negotiate a valuation on the basis of stabilised — if heavily adjusted — FCF. Current bond trading still reflects more of a SOTP / cycle-average valuation framework than a DCF-based approach, with excess cash receiving little credit given expected burn (Recap Scenario; DCF).
- We expect another restructuring before maturity. In that scenario, the SSNs remain the likely fulcrum, and the key question over the next two years is whether operational recovery can progress sufficiently to support a consensual EV framework before liquidity pressure re-emerges (Recap Scenario; Model). But SVP has one more ace up its sleeve - the drop-down of the EWP business (Legal).
- EWP operates as a commodity business reliant on resin (15% of COS, chiefly sourced from Silekol) and wood inputs, with demand tied to the cyclical DACH renovation market and concentrated premium suppliers; volumes collapse when rental yields compress, as they did in recent years. (Industry). Management, however, has been signalling green shoots in the sector (current trading).
- Silekol sources urea on multi-year contracts with groups like Grupa Azoty, stabilising supply, and its new Stettin facility should begin shielding it from commodity price swings; its downstream resin applications are broad, but it remains a small player in a commoditised market (Industry).
- The divisions share little synergy—only ~20–25% of Silekol sales go to Pfleiderer—and are now managed separately to facilitate a potential break-up (Company).
- Both units are highly pro-cyclical. While Silekol’s raw-material warehouse (H225) will help dampen input swings but cannot solve demand cyclicality (Company).
Current Trading:
- Pfleiderer now has two years to turn around to a point where a valuation can be based on cash flow generation. This is a volatile business, and a sharp turnaround is not impossible. SVP know that.
- The Maple transaction appears broadly creditor-friendly despite limited disclosure. We struggle to imagine a better outcome for creditors, although we don't know the dynamics between them.
- EWP trading stabilised operationally. Q4 volumes were flat, and pricing improved, while EBITDA weakness was largely distorted by unusually strong Q4 2024 one-offs and CO2 timing benefits.
- Silekol execution remains on track, with Project Nord operationally complete and full EBITDA contribution expected through 2026. Cost savings at EWP remain slow, while capex increased and working capital benefited from a sizeable payables build.
- Management executes on what it can control.
Key Value Drivers:
- Pfleiderer is cyclical. It should respond well to any uplift in German construction, which in turn should be less sensitive to Iran than, for instance, real estate hybrids. Construction is a longer-term bet.
- Clarity alone on the structure and bondholder positions relative to one another should drive liquidity and possibly trading levels. We might get that clarity on the Q126 call in May.
- Movement in the German market for land plots, as can be observed at Adler, for instance, is a fair early indicator that the downstream sector is thawing. This will take time, however.
- It is hard to imagine that Pfleiderer won't ever return to its previous size. Its competitive position remains undiminished. The question is only who controls what when that time comes.
- Fundamentally (last but not least), we have given Silekol full credit for its Nord facility and expect those ~€20m of earnings/savings to materialise from this year.
Key Risks:
- The bonds are hard to buy without better disclosure. Any non-pro rata distribution would have to be ruled out first, although if, despite the A&E amendment, there had been a non-pro rata deal, we'd have heard of it by now.
- Two creditors control the majority of the bonds, and only a few more will take it to the higher thresholds we would not bet on a par take-out at maturity. Any position would therefore have to heavily rest on a good legal analysis factoring in this dynamic, and potentially size to block the worst.
- Since there will likely be a third restructuring, these bonds should pay a good running yield, but will not trade all that well in the next two years.
Wolfgang
T: +44 203 744 7003
www.sarria.co.uk